Researchers repair acute spinal cord injury in monkeys

June 5, 2018 by Christopher Packham, Medical Xpress report
CST tracking with unilateral BDA injections. (A) A diagram of BDA injections in uninjured and NT3-chitosan monkeys. (B–D) Longitudinal sections of monkey spinal cord 11 wk after BDA injections in normal (uninjured, animal 30) (B), lesion control (animal 5) (C), and NT3-chitosan (animal 18) (D) monkeys more than a year after the initial operation. DAPI (blue), BDA (red), and GFAP (green) fluorescent images are shown. ROI, region of interest; small white arrows marked regenerated BDA-positive fibers. Credit: (c) 2018 PNAS. DOI: 10.1073/pnas.1804735115

Spinal cord injuries are among the most severe and difficult-to-treat medical conditions, usually resulting in permanent disability including loss of muscle function, sensation and autonomic functions. Medical research is now on the cusp of treating severe spinal cord injuries by inducing the repair of spinal nerves, and scientists have made strides in recent years with rodents and primates.

Using chitosan loaded with neurotrophin-3 (NT3), a collaborative of Chinese medical researchers now reports the successful and subsequent functional recovery of rhesus monkeys with induced acute . Though previous studies of the same treatment in rodents showed promise, these are the first results in primates, which the researchers say strongly implies its medical relevance for humans. They have published their results in The Proceedings of the National Academy of Sciences.

Chitosan is a polysaccharide derived from the chitinous shells of shrimp and other crustaceans. It has medical applications in the reduction of bleeding and as an antibacterial agent. It is also used as a drug delivery vehicle. NT3 is a neurotrophic factor that encourages the growth and differentiation of new neurons and synapses.

Spinal cord treatment and recovery is inhibited by a number of factors. Neurons in the central nervous system (CNS) do not easily regenerate in the best of conditions, and are further inhibited after injury by inflammatory cytokines and other factors.

Previous efforts at treatment have aimed at making the post-injury CNS environment less hostile to nerve regeneration, and although researchers made some headway with rodents, these results do not translate well to humans. The researchers wanted to translate previous results from studies to the treatment of non-human primates. For ethical reasons regarding the overuse of primates in medical research, they eliminated trials of several less successful variants of the chitosan-NT3 treatment and focused only on the most successful method.

In the new study, the researchers inserted the chitosan-NT3 compound into one-centimeter gaps in hemisectioned (partially severed) thoracic spinal cords of adult rhesus monkeys. Chitosan serves as a matrix scaffold that contains and gradually releases NT3 to the injury site over a relatively long period. In the rodent studies, the NT3-chitosan scaffold inhibited inflammatory cells and attracted endogenous neural stem cells to proliferate, differentiate and eventually form neuronal networks to transmit neural signals to and from the brain.

Using a non-invasive combination of outcome measures including fMRI, magnetic diffusion tensor imaging, and kinematics walking analyses, the researchers confirmed similar results in the . They were also able to confirm that monkeys with smaller post-treatment spinal lesions had better walking behavior. This is likely due to the anti-inflammatory action of chitosan-NT3.

The authors write, "This study using nonhuman primates represents a substantial advancement in translating our initial study using rodents to human therapy." While the study was focused on the treatment of acute injury, they believe it will also prove applicable in treatment of chronic spinal injury.

Explore further: Scientists discover new way to help nerve regeneration in spinal cord injury

More information: NT3-chitosan enables de novo regeneration and functional recovery in monkeys after spinal cord injury. PNAS. DOI: 10.1073/pnas.1804735115

Abstract
Spinal cord injury (SCI) often leads to permanent loss of motor, sensory, and autonomic functions. We have previously shown that neurotrophin3 (NT3)-loaded chitosan biodegradable material allowed for prolonged slow release of NT3 for 14 weeks under physiological conditions. Here we report that NT3-loaded chitosan, when inserted into a 1-cm gap of hemisectioned and excised adult rhesus monkey thoracic spinal cord, elicited robust axonal regeneration. Labeling of cortical motor neurons indicated motor axons in the corticospinal tract not only entered the injury site within the biomaterial but also grew across the 1-cm-long lesion area and into the distal spinal cord. Through a combination of magnetic resonance diffusion tensor imaging, functional MRI, electrophysiology, and kinematics-based quantitative walking behavioral analyses, we demonstrated that NT3-chitosan enabled robust neural regeneration accompanied by motor and sensory functional recovery. Given that monkeys and humans share similar genetics and physiology, our method is likely translatable to human SCI repair.

Related Stories

Scientists discover new way to help nerve regeneration in spinal cord injury

December 11, 2017
There is currently no cure for spinal cord injury or treatment to help nerve regeneration so therapies offering intervention are limited. People with severe spinal cord injuries can remain paralysed for life and this is often ...

Spinal cord injury affects the heart

December 12, 2017
Spinal cord injury affects the heart, that's what research published in Experimental Physiology and carried out by researchers from University of British Columbia, Canada has found.

Recovery from spinal cord injuries can be predicted

March 8, 2018
Injuries to the spinal cord result in tissue loss in the spinal cord and brain. These neurodegenerative changes can be analyzed in detail using neuroimaging methods. University of Zurich researchers have now, for the first ...

Researchers use human neural stem cell grafts to repair spinal cord injuries in monkeys

February 26, 2018
Led by researchers at University of California San Diego School of Medicine, a diverse team of neuroscientists and surgeons successfully grafted human neural progenitor cells into rhesus monkeys with spinal cord injuries. ...

Paraplegic rats walk and regain feeling after stem cell treatment

November 16, 2017
Engineered tissue containing human stem cells has allowed paraplegic rats to walk independently and regain sensory perception. The implanted rats also show some degree of healing in their spinal cords. The research, published ...

Recommended for you

Study of protein 'trafficker' provides insight into autism and other brain disorders

September 22, 2018
In the brain, as in business, connections are everything. To maintain cellular associates, the outer surface of a neuron, its membrane, must express particular proteins—proverbial hands that reach out and greet nearby cells. ...

Breast milk may be best for premature babies' brain development

September 21, 2018
Babies born before their due date show better brain development when fed breast milk rather than formula, a study has found.

Early warning sign of psychosis detected

September 21, 2018
Brains of people at risk of psychosis exhibit a pattern that can help predict whether they will go on to develop full-fledged schizophrenia, a new Yale-led study shows. The findings could help doctors begin early intervention ...

White matter repair and traumatic brain injury

September 20, 2018
Traumatic brain injury (TBI) is a leading cause of death and disability in the U.S., contributing to about 30 percent of all injury deaths, according to the CDC. TBI causes damage to both white and gray matter in the brain, ...

Gut branches of vagus nerve essential components of brain's reward and motivation system

September 20, 2018
A novel gut-to-brain neural circuit establishes the vagus nerve as an essential component of the brain system that regulates reward and motivation, according to research conducted at the Icahn School of Medicine at Mount ...

Genomic dark matter activity connects Parkinson's and psychiatric diseases

September 20, 2018
Dopamine neurons are located in the midbrain, but their tendril-like axons can branch far into the higher cortical areas, influencing how we move and how we feel. New genetic evidence has revealed that these specialized cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.